Allergy Therapeutics's market cap is currently £343.18M. The company's EPS TTM is p-0.01; its P/E ratio is ―; Allergy Therapeutics is scheduled to report earnings on March 5, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 24	Jun 23	Jun 22	Jun 21	Jun 20
Income Statement
Total Revenue	£ 55.20M	£ 59.59M	£ 72.77M	£ 84.33M	£ 78.20M
Gross Profit	£ 29.74M	£ 32.69M	£ 48.95M	£ 61.80M	£ 57.51M
Operating Income	£ -35.26M	£ -34.85M	£ -13.00M	£ 2.64M	£ 4.46M
EBITDA	£ -30.74M	£ -36.24M	£ -8.69M	£ 7.61M	£ 11.69M
Net Income	£ -40.22M	£ -43.07M	£ -13.78M	£ 2.89M	£ 7.06M
Balance Sheet
Cash & Short-Term Investments	£ 12.91M	£ 14.85M	£ 20.52M	£ 40.27M	£ 36.96M
Total Assets	£ 64.83M	£ 66.77M	£ 72.95M	£ 88.09M	£ 86.22M
Total Debt	£ 30.99M	£ 35.99M	£ 10.53M	£ 11.17M	£ 12.18M
Net Debt	£ 18.07M	£ 21.14M	£ -9.99M	£ -29.10M	£ -24.78M
Total Liabilities	£ 61.12M	£ 64.70M	£ 35.18M	£ 39.55M	£ 42.44M
Stockholders' Equity	£ 3.71M	£ 2.07M	£ 37.77M	£ 48.53M	£ 43.78M
Cash Flow
Free Cash Flow	£ -35.54M	£ -35.59M	£ -17.17M	£ 5.95M	£ 9.73M
Operating Cash Flow	£ -32.14M	£ -30.92M	£ -14.11M	£ 8.52M	£ 12.28M
Investing Cash Flow	£ -1.20M	£ -4.67M	£ -3.06M	£ -2.76M	£ -2.77M
Financing Cash Flow	£ 31.43M	£ 29.91M	£ -2.64M	£ -2.03M	£ -110.00K

Currency in GBP

Allergy Therapeutics Earnings and Revenue History

Income Statement >

Allergy Therapeutics Debt to Assets

Balance Sheet >

Allergy Therapeutics Cash Flow

Cash Flow >

Allergy Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing